🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
148,46 USD
Máx. histórico
156,92
14 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-5,39%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,24%
Cierre anterior
150,33
Rango de hoy
146,28 – 149,59
Volumen hoy
10.884.998
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 118,77 (puede no estar actualizado)
- Dividend yield
- 2,26% (puede no estar actualizado)
- Precio objetivo analistas
- 150,42 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 hora
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 04/09/1996 | 0,1908 USD |
| 06/06/1996 | 0,1622 USD |
| 06/03/1996 | 0,1622 USD |
| 06/12/1995 | 0,1622 USD |
| 05/09/1995 | 0,1622 USD |
| 02/06/1995 | 0,1431 USD |
| 03/03/1995 | 0,1431 USD |
| 02/12/1994 | 0,1431 USD |
| 02/09/1994 | 0,1431 USD |
| 02/06/1994 | 0,1336 USD |
| 02/03/1994 | 0,1336 USD |
| 02/12/1993 | 0,1336 USD |
| 02/09/1993 | 0,1336 USD |
| 02/06/1993 | 0,1193 USD |
| 02/03/1993 | 0,1193 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 20/07/1993 | 15,68 | 16,28 | 15,63 | 15,86 | +3,50% | 4,18% | 7.325.101 |
| 19/07/1993 | 15,74 | 15,80 | 15,15 | 15,33 | -3,02% | 4,17% | 8.763.166 |
| 16/07/1993 | 15,92 | 15,98 | 15,74 | 15,80 | -1,85% | 1,50% | 7.813.678 |
| 15/07/1993 | 16,28 | 16,34 | 15,98 | 16,10 | -2,88% | 2,20% | 7.368.698 |
| 14/07/1993 | 16,46 | 16,64 | 16,40 | 16,58 | +0,72% | 1,45% | 3.423.397 |
| 13/07/1993 | 16,34 | 16,58 | 16,28 | 16,46 | +0,00% | 1,82% | 4.629.435 |
| 12/07/1993 | 16,46 | 16,52 | 16,40 | 16,46 | -0,72% | 0,72% | 3.024.109 |
| 09/07/1993 | 16,58 | 16,64 | 16,40 | 16,58 | +0,00% | 1,44% | 4.098.518 |
| 08/07/1993 | 16,40 | 16,88 | 16,34 | 16,58 | +1,46% | 3,27% | 5.537.632 |
| 07/07/1993 | 16,40 | 16,58 | 16,28 | 16,34 | +0,00% | 1,82% | 4.732.349 |
| 06/07/1993 | 16,64 | 16,76 | 16,34 | 16,34 | -0,72% | 2,51% | 3.727.317 |
| 02/07/1993 | 16,64 | 16,70 | 16,46 | 16,46 | -1,43% | 1,43% | 4.114.238 |
| 01/07/1993 | 16,70 | 16,82 | 16,40 | 16,70 | -1,41% | 2,50% | 7.735.078 |
| 30/06/1993 | 17,47 | 17,65 | 16,82 | 16,94 | -3,40% | 4,78% | 4.564.250 |
| 29/06/1993 | 16,94 | 17,59 | 16,94 | 17,53 | +2,44% | 3,87% | 3.476.845 |
| 28/06/1993 | 17,47 | 17,53 | 17,00 | 17,12 | -1,71% | 3,07% | 3.389.232 |
| 25/06/1993 | 17,41 | 17,53 | 17,24 | 17,41 | +0,34% | 1,71% | 2.051.146 |
| 24/06/1993 | 17,18 | 17,47 | 17,18 | 17,35 | +1,04% | 1,74% | 4.221.763 |
| 23/06/1993 | 17,12 | 17,29 | 17,06 | 17,18 | -0,69% | 1,39% | 4.506.190 |
| 22/06/1993 | 17,59 | 17,65 | 17,18 | 17,29 | -2,03% | 2,71% | 4.917.845 |
| 21/06/1993 | 17,77 | 17,83 | 17,59 | 17,65 | +0,00% | 1,34% | 2.966.888 |
| 18/06/1993 | 18,19 | 18,25 | 17,65 | 17,65 | -4,21% | 3,28% | 7.472.450 |
| 17/06/1993 | 18,37 | 18,55 | 18,31 | 18,43 | +0,33% | 1,30% | 3.251.106 |
| 16/06/1993 | 18,19 | 18,37 | 18,01 | 18,37 | +1,32% | 1,97% | 3.820.798 |
| 15/06/1993 | 18,55 | 18,55 | 18,07 | 18,13 | -2,56% | 2,57% | 3.962.278 |
| 14/06/1993 | 18,49 | 18,67 | 18,43 | 18,61 | +0,97% | 1,29% | 3.887.032 |
| 11/06/1993 | 18,13 | 18,43 | 18,01 | 18,43 | +2,66% | 2,30% | 4.223.440 |
| 10/06/1993 | 17,53 | 18,01 | 17,53 | 17,95 | +2,38% | 2,72% | 4.177.328 |
| 09/06/1993 | 17,47 | 17,65 | 17,35 | 17,53 | +0,69% | 1,71% | 2.978.416 |
| 08/06/1993 | 17,41 | 17,59 | 17,35 | 17,41 | -0,34% | 1,37% | 3.782.861 |